Fresenius Kabi AG

News and overview for Fresenius Kabi AG

Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc. [Press Release]
Business Wire | 22 days 11 hours 11 minutes ago
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ), which acquired APP Pharmaceuticals, Inc., September 10, 2008, today announced the election of Bernhard Hampl, Ph.D. to its Board of Directors effective November 1, 2009. Dr. Hampl, also named as Executive Chairman of the Board, succeeds current Chairman Dr. Ulf M. Schneider. Dr. Schneider will continue to serve on the Board of Directors and as a member of the Audit Committee.


Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q [Press Release]
Business Wire | 22 days 11 hours 14 minutes ago
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has filed its Form 10-Q with the Securities and Exchange Commission. Fresenius Kabi Pharmaceuticals Holding, Inc., acquired APP Pharmaceuticals, Inc., on September 10, 2008. The Form 10-Q details the Company’s unaudited financial statements for the quarter ending September 30, 2009.


Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein [Press Release]
PRNewswire | 27 days 13 hours 40 minutes ago
...of Euro 443 million. Fresenius Kabi AG is a 100% subsidiary of the health care group Fresenius SE. For more information...8406,frank.feller@fresenius-kabi.com; or Olaf Walter...Coagulation, of Octapharma AG, +41-55-451-21...


Research and Markets: In-Depth Information and Data on Taiwan Drug Delivery Devices, Including Investment Opportunities, Analysis and Forecasts to 2015 [Press Release]
Business Wire | 37 days 9 hours 57 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/10aeaf/taiwan_drug_delive) has announced the addition of Global Markets Direct's new report "Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 Offers Detailed and Comprehensive Coverage [Press Release]
Business Wire | 41 days 17 hours 10 minutes ago
Research and Markets(http://www.researchandmarkets.com/research/99e437/israel_drug_delive) has announced the addition of Global Markets Direct's new report "Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 - Now Available [Press Release]
Business Wire | 43 days 1 hour 44 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/fad8d5/south_africa_drug) has announced the addition of Global Markets Direct's new report "South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Reportlinker Adds Gastrointestinal Endoscopy Devices Report [Press Release]
PRNewswire | 77 days 20 hours 24 minutes ago
...profiles 32 companies including many key and niche players such as Boston Scientific Corporation, Conmed Corporation, Fresenius Kabi AG, Fujifilm, Given Imaging, Ltd., Hobbs Medical, Inc., Hoya Corporation, Johnson & Johnson, Ethicon Endo...


Research and Markets: Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 [Press Release]
Business Wire | 42 days 19 hours 24 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/73dff3/netherlands_drug_d) has announced the addition of Global Markets Direct's new report "Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: Argentina Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015: In-Depth Information and Data [Press Release]
Business Wire | 40 days 21 hours 4 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/36bdba/argentina_drug_del) has announced the addition of Global Markets Direct's new report "Argentina Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts Through to 2015 [Press Release]
Business Wire | 42 days 19 hours 48 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/373a36/north_america_drug) has announced the addition of Global Markets Direct's new report "North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and data relating to North America drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and compan...


Research and Markets: Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 - Now Available [Press Release]
Business Wire | 43 days 1 hour 38 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/5b0364/mexico_drug_delive) has announced the addition of Global Markets Direct's new report "Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: Asia-Pacific Drug Delivery Devices Report - Investment Opportunities, Analysis and Forecasts to 2015 [Press Release]
Business Wire | 42 days 7 hours 8 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/25f111/asiapacific_drug) has announced the addition of Global Markets Direct's new report "Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: South and Central America Drug Delivery Devices Report - Investment Opportunities, Analysis and Forecasts to 2015 [Press Release]
Business Wire | 42 days 21 hours 58 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/1f7019/south_and_central) has announced the addition of Global Markets Direct's new report "South and Central America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


Research and Markets: Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 [Press Release]
Business Wire | 41 days 20 hours 5 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/518ffd/belgium_drug_deliv) has announced the addition of Global Markets Direct's new report "Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.


New market research report on Taiwan drug delivery devices market
News-Medical.Net | 37 days 35 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/10aeaf/taiwan_drug_delive) has announced the addition of Global Markets Direct's new report "Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.





 1  2   Next >

18 Results

Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Company Overview


Company: Fresenius Kabi AG
Industry: Medical Equipment & Supplies
Website: http://www.fresenius-kabi.com

Fresenius Kabi isn't one to stray from the sight of blood; to the contrary, the company's life depends on it. A subsidiary of Fresenius SE -- to which it contributes more than 15% of its annual sales -- the unit is a leading provider of a variety of transfusion products and devices. Fresenius Kabi's Voluven product is the top-selling artificial colloid -- a blood volume substitute used after trauma -- outside North America. Other infusion products include products for fluid and blood replacement, generic anesthetics and other IV-administered drugs, and medical devices such as insulin delivery pumps. Fresenius Kabi also produces clinical nutrition products for patients who are unable to digest normal food.


Key Numbers

Sales in U.S. Dollars (mil.) 0 ()
One-year % Growth in Sales 0.0 ()
Net Income in U.S. Dollars (mil.) 0 ()
One-year % Growth in Net Income 0.0 ()
Number of Employees 0 (0)
One-year % Growth in Number of Employees 0.0 (0)
Fiscal Year-End December